Is it time to reconsider combination lipid therapy in high-risk diabetic patients?
| Cobertura |
England |
|---|---|
| Data(s) |
01/06/2016
|
| Formato |
310 - 311 |
| Identificador |
http://www.ncbi.nlm.nih.gov/pubmed/27145105 00041433-201660000-00017 Curr Opin Lipidol, 2016, 27 (3), pp. 310 - 311 http://hdl.handle.net/10161/12515 1473-6535 |
| Idioma(s) |
eng |
| Relação |
Curr Opin Lipidol 10.1097/MOL.0000000000000306 |
| Tipo |
Journal Article |
